ZEN-BIO, INC.

Address

P.O. BOX 13888
3200 CHAPEL HILL-NELSON BLVD.
RTP, NC, 27709-3888

Information

DUNS: 799863261
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. A novel class of anti-acne therapeutics

    Amount: $224,999.00

    DESCRIPTION provided by applicant Acne Vulgaris is a common skin disorder that affects of the population typically teenagers and young adults Over million people in the US are affected by ...

    SBIRPhase I2016Department of Health and Human Services
  2. Development and validation of a human brown adipocyte system

    Amount: $777,915.00

    Project Summary The activation and recruitment of brown adipose tissue has become an exciting target in the fight against obesity and its related metabolic diseases Brown adipose tissue differs from ...

    SBIRPhase II2016Department of Health and Human Services
  3. IGF OT IGF HIGH CONTENT SCREENING FOR HUMAN PRIMARY PANCREATIC CELL TYPE SPECIFIC TOXICANTS

    Amount: $224,901.00

    Not Available

    SBIRPhase I2015Department of Health and Human Services
  4. Development and validation of a human brown adipocyte system

    Amount: $224,320.00

    DESCRIPTION provided by applicant The activation and recruitment of brown adipose tissue has become an exciting target in the fight against obesity and its related metabolic diseases Brown adipose ...

    SBIRPhase I2015Department of Health and Human Services
  5. Development of a drug discovery platform for human islets

    Amount: $1,754,814.00

    DESCRIPTION provided by applicant Diabetes and diabetes related co morbidities are at epidemic proportions and an enormous burden to our healthcare system Although there has been significant progr ...

    SBIRPhase II2014Department of Health and Human Services
  6. Selective Fyn kinase inhibitors for treatment of metabolic disease

    Amount: $1,498,715.00

    DESCRIPTION provided by applicant Metabolic diseases such as type diabetes T D obesity and their related co morbidities have reached epidemic proportions worldwide While progress continues to ...

    SBIRPhase II2014Department of Health and Human Services
  7. Identification of potent and selective GLI1 inhibitors

    Amount: $289,934.00

    DESCRIPTION (provided by applicant): Characterization of human tumor samples and cell lines in combination with inhibitor studies in animal models has established a central role for the Hh pathway in ...

    STTRPhase I2013Department of Health and Human Services
  8. Development of a Drug Discovery Platform for Human Islets

    Amount: $462,386.00

    DESCRIPTION (provided by applicant): Diabetes and diabetes-related co-morbidities are at epidemic proportions and an enormous burden to our healthcare system. Although there has been significant progr ...

    SBIRPhase I2012Department of Health and Human Services
  9. Development of a human skeletal muscle cell-based high throughput screen for musc

    Amount: $251,144.00

    DESCRIPTION (provided by applicant): Skeletal muscle wasting is a serious condition prevalent in the aging population (sarcopenia) and in a variety of specific diseases. This condition results in loss ...

    SBIRPhase I2011Department of Health and Human Services
  10. Selective Fyn kinase inhibitors for treatment of metabolic disease

    Amount: $350,681.00

    DESCRIPTION (provided by applicant): Metabolic diseases such as type 2 diabetes (T2D), obesity and their related co-morbidities have reached epidemic proportions worldwide. While progress continues to ...

    SBIRPhase I2011Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government